Sophion Bioscience A/S is a Danish A/S based in Ballerup, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2000, the company has 87 employees and reported revenue of 102,1 mio. kr. in its latest annual filing.
102,1 mio. kr.
−15% vs 2024
Solidity ratio Equity ÷ Total assets × 100 2021 2025
Liquidity ratio Current assets ÷ Short-term debt 2021 2025
Return on assets (ROA) Net profit ÷ Total assets × 100 2021 2025
EBITDA — year on year DKK millions 93M 70M 47M 23M 0M 2021: 45M 45M 2021 2022: 75M (+67% vs 2021) 75M +67% 2022 2023: 56M (-25% vs 2022) 56M -25% 2023 2024: 58M (+4% vs 2023) 58M +4% 2024 2025: 22M (-62% vs 2024) 22M -62% 2025
Key figures Annual report 2025 Revenue 102,1 mio. kr. -15% EBITDA 21,7 mio. kr. -62% Net profit 4,4 mio. kr. -89% Total assets 237,6 mio. kr. -4% Equity 178,4 mio. kr. -7% Employees 87 —
Legal name
SOPHION BIOSCIENCE A/S
Founded
7 February 2000 · 26 years
Share capital
DKK 50.000.000
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede bestyrelse eller af to af bestyrelsens medlemmer i forening eller af et bestyrelsesmedlem i fællesskab med en direktør
Company purpose
Selskabets formål er at drive forskning, handel, fabrikation og dermed beslægtet virksomhed primært inden for medicinalbranchen
(no translation available)
Advertising protection
Active — opted out of marketing use
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.comExplore Companies in Research and experimental development on natural sciences and engineering Companies in Ballerup All Denmark companiesFinancial development In its most recent annual report (2025), Sophion Bioscience A/S reported a gross profit of 102,1 mio. kr., a decrease of 15% on the year before. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net profit of 4,4 mio. kr., and the EBITDA margin stood at 21.3%.
At the end of 2025, equity financed 75.1% of the balance sheet, and current assets covered short-term debt 2.6 times. Sophion Bioscience A/S is one of 2 companies registered under Research and experimental development on natural sciences and engineering in Denmark.
Frequently asked questions What is the CVR number of Sophion Bioscience A/S? Sophion Bioscience A/S is registered with CVR / Virk under CVR 10021065.
What is the revenue of Sophion Bioscience A/S? Sophion Bioscience A/S reported revenue of 102,1 mio. kr. in 2025.
How many employees does Sophion Bioscience A/S have? Sophion Bioscience A/S employs 87 people as of the latest annual report.
Who is the CEO of Sophion Bioscience A/S? Michel Krall Jürgens is the CEO of Sophion Bioscience A/S, in role since 2024.
Who is the chairman of Sophion Bioscience A/S? Harald Høegh chairs the board of Sophion Bioscience A/S, in role since 2025.
Where is Sophion Bioscience A/S headquartered? Sophion Bioscience A/S's registered address is Industriparken 39.
More on Sophion Bioscience A/S